Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 76-82

  Willemsen, Suzan ^a   Hartog, Jasper W L ^a   Hummel, Yoran M ^a   Van Ruijven, Marieke H I ^a   Van Der Horst, Iwan C C ^a   Van Veldhuisen, Dirk J ^a   Voors, Adriaan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Advanced glycation end products; Diabetes; Diastolic function; Heart failure

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; ARTICLE; AUTOFLUORESCENCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

AGED; DIABETES MELLITUS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART FAILURE, DIASTOLIC; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; OXYGEN CONSUMPTION; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 78650358520     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq168     Document Type: Article

References (25)

1. Dickstein K Cohen-Solal A Filippatos G McMurray JJ Ponikowski P Poole-Wilson PA Stromberg A van Veldhuisen DJ Atar D Hoes AW Keren A Mebazaa A Nieminen M Priori SG Swedberg K Vahanian A Camm J De Caterina R Dean V Dickstein K Filippatos G Funck-Brentano C Hellemans I Kristensen SD McGregor K Sechtem U Silber S Tendera M Widimsky P Zamorano JL Tendera M Auricchio A Bax J Bohm M Corra U della Bella P Elliott PM Follath F Gheorghiade M Hasin Y Hernborg A Jaarsma T Komajda M Kornowski R Piepoli M Prendergast B Tavazzi L Vachiery JL Verheugt FW Zamorano JL Zannad F. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
2. Fox CS Pencina MJ Meigs JB Vasan RS Levitzky YS D'Agostino RB Sr. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation 2006;113:2914-2918.
3. Nichols GA Gullion CM Koro CE Ephross SA Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 2004;27: 1879-1884.
4. Preis SR Pencina MJ Hwang SJ D'Agostino RB Sr Savage PJ Levy D Fox CS. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009;120: 212-220.
5. Hartog JW Voors AA Bakker SJ Smit AJ van Veldhuisen DJ. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail 2007;9:1146-1155.
6. Miyata T Sugiyama S Saito A Kurokawa K. Reactive carbonyl compounds related uremic toxicity ('carbonyl stress'). Kidney Int Suppl 2001;78:S25-S31.
7. Smit AJ Hartog JW Voors AA van Veldhuisen DJ. Advanced glycation endpro-ducts in chronic heart failure. Ann N Y Acad Sci 2008;1126:225-230.
8. Wu YW Hsu CL Wang SS Tsai MW Chu SH Chen YS Yang WS Wu YT. Impaired exercise capacity in diabetic patients after coronary bypass surgery: effects of diastolic and endothelial function. Cardiology 2008;110:191-198.
9. Loimaala A Groundstroem K Rinne M Nenonen A Huhtala H Vuori I. Exercise training does not improve myocardial diastolic tissue velocities in Type 2 diabetes. Cardiovasc Ultrasound 2007;5:32.
10. Parthenakis FI Kanoupakis EM Kochiadakis GE Skalidis EI Mezilis NE Simantirakis EN Kanakaraki MK Vardas PE. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J 2000;140:338-344.
11. Willemsen S Hartog JW Hummel YM Posma JL van Wijk LM van Veldhuisen DJ Voors AA. Effects of alagebrium an advanced glycation end-product breaker in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial. Eur J Heart Fail 2010;12:294-300.
12. Meerwaldt R Hartog JW Graaff R Huisman RJ Links TP den Hollander NC Thorpe SR Baynes JW Navis G Gans RO Smit AJ. Skin autofluorescence a measure of cumulative metabolic stress and advanced glycation end products predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693.
13. Meerwaldt R Links T Graaff R Thorpe SR Baynes JW Hartog J Gans R Smit A. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005; 1043:290-298.
14. Nagueh SF Appleton CP Gillebert TC Marino PN Oh JK Smiseth OA Waggoner AD Flachskampf FA Pellikka PA Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133.
15. Hummel YM Klip IJ de Jong RM Pieper PG van Veldhuisen DJ Voors AA. Dias-tolic function measurements and diagnostic consequences: a comparison of pulsed wave- and color-coded tissue Doppler imaging. Clin Res Cardiol 2010;99: 453-458.
16. Sheffield LT Roitman D. Stress testing methodology. Prog Cardiovasc Dis 1976;19: 33-49.
17. Solang L Malmberg K Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J 1999;20:789-795.
18. van der Horst IC de Boer RA Hillege HL Boomsma F Voors AA van Veldhuisen DJ. Neurohormonal profile of patients with heart failure and diabetes. Neth Heart J 2010;18:190-196.
19. Lapu-Bula R Robert A De Kock M D'Hondt AM Detry JM Melin JA Vanoverschelde JL. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1999;83:728-734.
20. Bursi F Weston SA Redfield MM Jacobsen SJ Pakhomov S Nkomo VT Meverden RA Roger VL. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-2216.
21. Cleland JG Tendera M Adamus J Freemantle N Polonski L Taylor J. The peri-ndopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27:2338-2345.
22. Stewart KJ. Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA 2002;288:1622-1631.
23. Van Veldhuisen DJ Cohen-Solal A Bohm M Anker SD Babalis D Roughton M Coats AJ Poole-Wilson PA Flather MD. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009;53:2150-2158.
24. Yip GW Wang M Wang T Chan S Fung JW Yeung L Yip T Lau ST Lau CP Tang MO Yu CM Sanderson JE. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics irbesartan and ramipril on quality of life exercise capacity left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008;94:573-580.
25. Yusuf S Pfeffer MA Swedberg K Granger CB Held P McMurray JJ Michelson EL Olofsson B Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-781.